Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioHarvest SciencesBHST -1.82%63 Cyclically Adjusted PB Ratio is 8.44 as of Jul. 14, 2026, which is 61% below its 10-year median of 21.70. GuruFocus rates BHST with a GF Score™ of 63/100 and a GF Value™ of $8.59 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,445 Consumer Packaged Goods companies, BioHarvest Sciences ranks worse than 94.6% on this metric.
The historical rank and industry rank for BioHarvest Sciences's Cyclically Adjusted PB Ratio or its related term are showing as below:
BHST'
s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 8.59 Med: 21.7 Max: 42.63
Current: 8.7
During the past years, BioHarvest Sciences's highest Cyclically Adjusted PB Ratio was 42.63. The lowest was 8.59. And the median was 21.70.
BHST's Cyclically Adjusted PB Ratio is ranked worse than 94.6% of 1445
companies
in the Consumer Packaged Goods industry
Industry Median: 1.25
vs BHST: 8.70
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
BioHarvest Sciences's adjusted book value per share data for the three months ended in Mar. 2026 was $1.016. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.32 for the trailing ten years ended in Mar. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
BioHarvest Sciences (NAS:BHST) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
BioHarvest Sciences Cyclically Adjusted PB Ratio Related Terms
BioHarvest Sciences Cyclically Adjusted PB Ratio Historical Data
* Premium members only.
The historical data trend for BioHarvest Sciences's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioHarvest Sciences Cyclically Adjusted PB Ratio Chart
BHST vs BRID, BOF, BFNH: Cyclically Adjusted PB Ratio Comparison
For the Packaged Foods subindustry, BioHarvest Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioHarvest Sciences Cyclically Adjusted PB Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where BioHarvest Sciences's Cyclically Adjusted PB Ratio falls into.
BioHarvest Sciences Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
BioHarvest Sciences's Cyclically Adjusted PB Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 8.44 mean?
BioHarvest Sciences (BHST) has a Cyclically Adjusted PB Ratio of 8.44 as of Jul. 14, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on BioHarvest Sciences and its competitors. This is 61% below median its historical median of 21.70. Over the past decade, BioHarvest Sciences' Cyclically Adjusted PB Ratio has ranged from 8.59 to 42.63. According to the industry distribution chart, BioHarvest Sciences ranks #1367 out of 1445 companies in the Consumer Packaged Goods industry, placing it in the top 94.6%.
Is BioHarvest Sciences' Cyclically Adjusted PB Ratio too high?
BioHarvest Sciences' current Cyclically Adjusted PB Ratio of 8.44 is 61% below median its 10-year median of 21.70. Over the past 10 years, this metric has ranged from a low of 8.59 to a high of 42.63. The Consumer Packaged Goods industry median Cyclically Adjusted PB Ratio is 1.25. BioHarvest Sciences' value of 8.44 is 575.2% above this industry median. Based on the distribution chart, BioHarvest Sciences ranks #1367 out of 1445 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, BioHarvest Sciences has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioHarvest Sciences' Cyclically Adjusted PB Ratio compare to BRID and BOF?
According to the Consumer Packaged Goods industry distribution chart, BioHarvest Sciences ranks #1367 out of 1445 companies for Cyclically Adjusted PB Ratio. This places BioHarvest Sciences in the lower half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.25. BioHarvest Sciences' value of 8.44 is 575.2% above this benchmark. Historically, BioHarvest Sciences' own Cyclically Adjusted PB Ratio has ranged from 8.59 to 42.63 over the past decade. While the company's 10-year median is 21.70 vs. the industry median of 1.25, BioHarvest Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Consumer Packaged Goods company?
The median Cyclically Adjusted PB Ratio among Consumer Packaged Goods companies is 1.25, based on 1,445 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioHarvest Sciences's current Cyclically Adjusted PB Ratio of 8.44 is 575.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on BioHarvest Sciences and its competitors. For the Consumer Packaged Goods industry, the median Cyclically Adjusted PB Ratio is 1.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioHarvest Sciences's current Cyclically Adjusted PB Ratio is 8.44, which is 61% below median its own 10-year median of 21.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioHarvest Sciences stock overvalued right now?
Based on GuruFocus' analysis, BioHarvest Sciences (BHST) is currently considered Possible Value Trap. The stock's GF Value™ is $8.59, compared to a current price of $2.70 — trading 68.6% below its estimated fair value. The current Cyclically Adjusted PB Ratio is 8.44, which is 61% below median its 10-year median of 21.70 and 575.2% above the Consumer Packaged Goods industry median of 1.25. BioHarvest Sciences' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For BioHarvest Sciences (BHST), the current Cyclically Adjusted PB Ratio is 8.44 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioHarvest Sciences (BHST) Overvalued in 2026?
Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued.
The current stock price of $2.70 is trading 68.6% below its estimated GF Value™ of $8.59.
GuruFocus considers BioHarvest Sciences to be Possible Value Trap.
Key valuation signals for BHST:
Cyclically Adjusted PB Ratio: 8.44 (61% below median its 10-year median of 21.70)
GF Value™: $8.59 vs. price of $2.70 (68.6% below fair value)
Industry Position: 575.2% above the Consumer Packaged Goods median (#1367 of 1445)
No single metric tells the full story. See the BHST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
63GF Score
Get the complete analysis for BHST
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BHST has been successfully added to your 
